Premium
Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab
Author(s) -
Sahlin Sven,
Lignell Börje,
Williams Maria,
Dastmalchi Maryam,
Orrego Abiel
Publication year - 2009
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2008.01320.x
Subject(s) - medicine , myositis , infliximab , methotrexate , inflammation , biopsy , dermatology , gastroenterology , pathology , disease
. Purpose: We report the successful use of infliximab in a young patient with idiopathic sclerosing orbital inflammation (myositis). Methods: We describe the patient’s medical records and review the literature. Results: Idiopathic myositis in this patient could not be satisfactorily treated with corticosteroids or chemotherapy. Biopsy showed sclerosing orbital inflammation. The patient had a prompt and sustained response with infliximab and methotrexate treatment. Conclusions: Infliximab and methotrexate might be considered in patients with idiopathic sclerosing orbital inflammation (myositis).